Daniel Morgenstern, Head of Clinical Trials at The Hospital for Sick Children, shared a post on LinkedIn:
“Double end-of-year updates for Optimise!
We are now open at BC Children’s Hospital in Vancouver completing the opening of the master protocol and first treatment arm across the three largest paediatric oncology centres in Canada.
We have also now activated our first site in Australia (Perth Children’s Hospital) on our second therapeutic arm, exploring immune checkpoint inhibitors in immune-infiltrated tumours.
Many thanks to everyone for all their work on this study over the last year and thanks to Cancer Research Society, Canadian Institutes of Health Research and Stand Up To Cancer for financial support.”
More posts featuring Daniel Morgenstern.